Advisors Capital Management’s Exagen XGN Stock Holding History

Advisors Capital Management’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-67,923	Closed	-$143K	–	465
2022 Q3	$143K	Buy	67,923 +27,050	+66%	+$151K	﹤0.01%	446
2022 Q2	$235K	Buy	40,873 +1,104	+3%	+$6.43K	0.01%	393
2022 Q1	$319K	Buy	39,769 +2,251	+6%	+$19.4K	0.01%	359
2021 Q4	$436K	Buy	37,518 +5,436	+17%	+$63.7K	0.01%	325
2021 Q3	$436K	Buy	32,082 +5,130	+19%	+$68.2K	0.01%	309
2021 Q2	$404K	Sell	26,952 -3,305	-11%	-$50.7K	0.01%	303
2021 Q1	$529K	Buy	+30,257	New	+$539K	0.02%	268

Other funds holding XGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Advisors Capital Management's XGN Position: Q4 2022 in Review

Advisors Capital Management sold out of Exagen (XGN) in Q4 2022, closing a stake of 67,923 shares — an estimated $143K sold.

Advisors Capital Management first reported a position in XGN in Q1 2021 and held it in 7 quarters. The position peaked at $529K in Q1 2021. 31 funds tracked by Wall St. Rank hold XGN as of Q4 2022.

Advisors Capital Management reported no remaining Exagen position as of Q4 2022 after selling out during the quarter.
Advisors Capital Management sold 67,923 Exagen shares in Q4 2022, an estimated $143K.
Advisors Capital Management first reported a position in Exagen in Q1 2021 and held it in 7 quarters.
Advisors Capital Management's Exagen position peaked at $529K in Q1 2021.
31 funds tracked by Wall St. Rank held Exagen as of Q4 2022.

Based on Advisors Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.